Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer

por Li, Weihua, Wan, Rui, Guo, Lei, Chang, Geyun, Jiang, Dong, Meng, Lin, Ying, Jianming
Publicado 2022

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

por Du, Xinyang, Bai, Hua, Wang, Zhijie, Daun, Jianchun, Liu, Zheng, Xu, Jiachen, Chang, Geyun, Zhu, Yixiang, Wang, Jie
Publicado 2022

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

por Yu, Ruofei, Bai, Hua, Li, Tangai, Gao, Bingyu, Han, Jiefei, Chang, Geyun, Zhang, Pei, Fei, Kailun, He, Xiran, Wang, Jie
Publicado 2021

Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer

por Chang, Geyun, Li, Weihua, Bai, Hua, Duan, Jianchun, Wang, Zhijie, Du, Xinyang, Yu, Ruofei, Wang, Yaxi, Wang, Minghao, Zhu, Yixiang, Zhang, Xue, Li, Li, Wan, Rui, Wang, Jie
Publicado 2022